SCHEMBL3987451

SCHEMBL3987451

CC(C)=NC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241578 0.75
SCHEMBL241577 0.75
SCHEMBL2354321 0.75
SCHEMBL15496657 0.75
SCHEMBL25031381 0.69
SCHEMBL21846441 0.69
SCHEMBL12386307 0.69
SCHEMBL4089433 0.69
SCHEMBL17032501 0.69
SCHEMBL14281104 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221839-A1 Preparation of an Atorvastatin Intermediate PFIZER INC. 2009-09-03 US claimed
EP-1922315-B1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE PFIZER SCIENCE & TECH LTD (IE) 2009-05-27 EP claimed
EP-1922315-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE Pfizer Science and Technology Ireland Limited (IE) 2008-05-21 EP claimed
WO-2007029216-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) 2007-03-15 WO claimed
US-12024500-B2 Five-membered ring-substituted pyridazinol compounds and derivatives, preparation methods, herbicidal compositions and applications thereof QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) 2024-07-02 US disclosed
US-20220400678-A1 OXIME ETHER COMPOUND AND APPLICATION THEREOF SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) 2022-12-22 US disclosed
US-11014909-B2 Heteroaromatic compounds and their use as dopamine D1 ligands PFIZER INC. (US) 2021-05-25 US disclosed
US-20210032229-A1 PYRIDINE RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) 2021-02-04 US disclosed
US-20200283407-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS PFIZER (US) 2020-09-10 US disclosed
EP-3395822-B1 ORGANOAMINOSILANES AND METHODS FOR MAKING SAME VERSUM MAT US LLC (US) 2020-03-25 EP disclosed
US-10294250-B2 Organoaminosilanes and methods for making same VERSUM MATERIALS US, LLC (US) 2019-05-21 US disclosed
EP-2913334-B1 Organoaminosilanes and methods for making same VERSUM MAT US LLC (US) 2018-12-19 EP disclosed
EP-1431316-B1 The in situ polymerization of monoethylenically unsaturated monomers with oligomeric or polymeric secondary amines BAYER MATERIALSCIENCE AG (DE) 2006-03-22 EP disclosed
US-20050154042-A1 N-alkyl pyrroles as HMG-CoA reductase inhibitors WARNER-LAMBERT COMPANY 2005-07-14 US disclosed
WO-2005056004-A1 N-ALKYL PYRROLES AS HMG-COA REDUCTASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-06-23 WO disclosed
US-20050043364-A1 Novel pyrrole-based HMG-CoA reductase inhibitors KENNEDY ROBERT MICHAEL (US) 2005-02-24 US disclosed
WO-2005014539-A2 PYRROLE-BASED HMG-COA REDUCTASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-02-17 WO disclosed
US-20040122169-A1 Situ polymerization of monoethylenically unsaturated monomers with oligomeric or polymeric secondary amines BAYER AKTIENGESELLSCHAFT (DE) 2004-06-24 US disclosed
EP-1431316-A1 The in situ polymerization of monoethylenically unsaturated monomers with oligomeric or polymeric secondary amines Bayer MaterialScience AG (DE) 2004-06-23 EP disclosed
EP-1428837-A1 The in situ polymerization of monoethylenically unsaturated monomers with oligomeric or polymeric secondary amines Bayer MaterialScience AG (DE) 2004-06-16 EP disclosed